(Health-NewsWire.Net, May 10, 2017 ) Gout is one type of arthritis, which is caused by the high levels of uric acid in the blood. The main symptoms of gout are sudden attack of burning pain, swelling in a joint, and stiffness, usually in toe. If it is not treated, over time, it can harm tendons, joints, and other tissues. NSAIDs and urate-lowering agents are preferred treatment options for gout.
Publisher's analysts forecast the global gout therapeutics market to grow at a CAGR of 17.16% during the period 2016-2020. For more information about this report: http://www.reportsweb.com/global-gout-therapeutics-market-2016-2020 Covered in this report The report covers the present scenario and the growth prospects of the global gout therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of gout and the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs.
The market is divided into the following segments based on geography: -Americas -APAC -EMEA
Publisher's report, Global Gout Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors -AstraZeneca -Horizon Pharma -Takeda Pharmaceuticals
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001453352/sample
Other prominent vendors -Ablynx - Alder Biopharmaceuticals -Antares Pharma - Astellas Pharma - Boehringer Ingelheim -Can-Fite BioPharma -Celgene - Celltrion - ChemoCentryx - CymaBay Therapeutics - Eisai - Eli Lilly - Gilead Sciences - GlaxoSmithKline - Incyte - Ironwood Pharmaceuticals - JW Pharmaceutical - KaloBios Pharmaceuticals - Lexicon Pharmaceuticals - LG Life Sciences - Merck - Morphotek - Novartis - Novo Nordisk - Regeneron Pharmaceuticals - Sandoz -Sanofi -Santarus - Selecta Biosciences - Teijin Pharma - UCB -Vertex Pharmaceuticals.
Market driver -Introduction of novel urate-lowering agents -For a full, detailed list, view our report
Market challenge -Low physician and patient awareness -For a full, detailed list, view our report
Market trend -Focus on regenerative medicines -For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001453352/buying .
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|